| The role of Nrf2 in liver disease: novel molecular mechanisms and therapeutic approaches D Xu, M Xu, S Jeong, Y Qian, H Wu, Q Xia, X Kong Frontiers in pharmacology 9, 1428, 2019 | 215 | 2019 |
| M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma X Qiu, S Yang, S Wang, J Wu, B Zheng, K Wang, S Shen, S Jeong, Z Li, ... Cancer Research 81 (18), 4778-4793, 2021 | 121 | 2021 |
| Role of osteopontin in liver diseases Y Wen, S Jeong, Q Xia, X Kong International journal of biological sciences 12 (9), 1121, 2016 | 108 | 2016 |
| Trajectory and Functional Analysis of PD‐1high CD4+CD8+ T Cells in Hepatocellular Carcinoma by Single‐Cell Cytometry and Transcriptome Sequencing B Zheng, D Wang, X Qiu, G Luo, T Wu, S Yang, Z Li, Y Zhu, S Wang, R Wu, ... Advanced Science 7 (13), 2000224, 2020 | 74 | 2020 |
| miRNA and lncRNA as biomarkers in cholangiocarcinoma (CCA) B Zheng, S Jeong, Y Zhu, L Chen, Q Xia Oncotarget 8 (59), 100819, 2017 | 62 | 2017 |
| Isolation of cancer‐associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma M Sha, S Jeong, B Qiu, Y Tong, L Xia, N Xu, J Zhang, Q Xia Cancer medicine 7 (9), 4665-4677, 2018 | 54 | 2018 |
| Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection S Jeong, Q Cheng, L Huang, J Wang, M Sha, Y Tong, L Xia, L Han, Z Xi, ... BMC cancer 17, 1-9, 2017 | 44 | 2017 |
| Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults S Jeong, YH Oh, S Choi, J Chang, SM Kim, JS Son, G Lee, JC Ahn, ... Clinical and Molecular Hepatology 28 (3), 510, 2022 | 32 | 2022 |
| Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance S Jeong, K Kim, J Chang, S Choi, SM Kim, JS Son, G Lee, W Kim, ... Annals of translational medicine 8 (21), 2020 | 28 | 2020 |
| Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma S Jeong, Y Tong, M Sha, J Gu, Q Xia Oncotarget 8 (10), 17292, 2017 | 28 | 2017 |
| Nervous system and primary liver cancer S Jeong, B Zheng, H Wang, Q Xia, L Chen Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1869 (2), 286-292, 2018 | 26 | 2018 |
| Rictor deficiency aggravates hepatic ischemia/reperfusion injury in mice by suppressing autophagy and regulating MAPK signaling D Xu, J Zhu, S Jeong, D Li, X Hua, L Huang, J Zhang, Y Luo, Q Xia Cellular Physiology and Biochemistry 45 (6), 2199-2212, 2018 | 25 | 2018 |
| Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram Y Ge, S Jeong, GJ Luo, YB Ren, BH Zhang, YJ Zhang, F Shen, QB Cheng, ... Hepatobiliary & Pancreatic Diseases International 19 (2), 138-146, 2020 | 24 | 2020 |
| Association of air pollutants with incident chronic kidney disease in a nationally representative cohort of Korean adults SY Hwang, S Jeong, S Choi, DH Kim, SR Kim, G Lee, JS Son, SM Park International journal of environmental research and public health 18 (7), 3775, 2021 | 22 | 2021 |
| Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma M Sha, S Jeong, X Wang, Y Tong, J Cao, HY Sun, L Xia, N Xu, ZF Xi, ... BMC cancer 19, 1-10, 2019 | 22 | 2019 |
| Transarterial chemoembolization: a favorable postoperative management to improve prognosis of hepatitis B virus-associated intrahepatic cholangiocarcinoma after surgical resection S Jeong, BO Zheng, J Wang, J Chi, Y Tong, L Xia, N Xu, J Zhang, X Kong, ... International Journal of Biological Sciences 13 (10), 1234, 2017 | 22 | 2017 |
| Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis M Sha, S Jeong, X Chen, Y Tong, J Cao, H Sun, L Xia, N Xu, X Wang, ... International journal of biological sciences 14 (10), 1333, 2018 | 21 | 2018 |
| Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinoma J Tang, CJ Sui, DF Wang, XY Lu, GJ Luo, Q Zhao, QY Lian, S Jeong, ... Theranostics 10 (12), 5384, 2020 | 18 | 2020 |
| Risk factors and survival outcomes of biliary complications after adult-to-adult living donor liver transplantation S Jeong, X Wang, P Wan, M Sha, J Zhang, L Xia, Y Tong, Y Luo, Q Xia United European Gastroenterology Journal 5 (7), 997-1006, 2017 | 17 | 2017 |
| Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis S Jeong, G Luo, ZH Wang, M Sha, L Chen, Q Xia Hepatology International 12, 330-338, 2018 | 16 | 2018 |
